Piperacillin/Tazobactam in the Treatment of Lower Respiratory Tract Infections: an Open Non-Comparative and Multicentered Trial
Author:
Publisher
Informa UK Limited
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology
Link
http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883
Reference20 articles.
1. Moosdeen F, Keeble J, Williams JD. Induction/inhibition of chromosomal β-lactamases by β-lactamase inhibitors. Rev Infect Dis 1986; 8 (suppl 5): 562–7.
2. Stratton CW, Weeks LS, Aldridge K. Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group. Diagn Microbiol Infect Dis 1992; 15: 321–30.
3. Jones RN, Pfaller MA, Fuchs PC, Aldridge K, Allen SD, Gerlach EH. Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains. Diagn Microbiol Infect Dis 1989; 12: 489–94.
4. Fass RJ, Prior RB. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate. Antimicrob Agents Chemother 1989; 33: 1268–74.
5. Bourgault AM, Lamothe F, Hoban DJ, et al. Survey of Bacteroides fragilis group susceptibility patterns in Canada. Antimicrob Agents Chemother 1992; 36: 343–7.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. No development of ciprofloxacin resistance in the Haemophilus species associated with pneumonia over a 10-year study;BMC Infectious Diseases;2015-11-13
2. Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?;Clinical Infectious Diseases;2006-01-15
3. Piperacillin/tazobactam versus cefotaxime plus metronidazole for the treatment of severe intra-abdominal infection in hospitalized pediatric patients;Current Therapeutic Research;2001-06
4. Treatment of Nosocomial Postoperative Pneumonia in Cancer Patients: A Prospective Randomized Study;Annals of Surgical Oncology;2001-03
5. Efficacy, safety, and tolerance of piperacillin/tazobactam compared to co-amoxiclav plus an aminoglycoside in the treatment of severe pneumonia;European Journal of Clinical Microbiology & Infectious Diseases;1998-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3